GR20060100539A - ΧΙΜΑΙΡΕΣ GnRH -ΛΕΥΚΟΤΟΞΙΝΩΝ - Google Patents

ΧΙΜΑΙΡΕΣ GnRH -ΛΕΥΚΟΤΟΞΙΝΩΝ

Info

Publication number
GR20060100539A
GR20060100539A GR20060100539A GR20060100539A GR20060100539A GR 20060100539 A GR20060100539 A GR 20060100539A GR 20060100539 A GR20060100539 A GR 20060100539A GR 20060100539 A GR20060100539 A GR 20060100539A GR 20060100539 A GR20060100539 A GR 20060100539A
Authority
GR
Greece
Prior art keywords
gnrh
leukotoxin
sequences
same
multimer
Prior art date
Application number
GR20060100539A
Other languages
English (en)
Inventor
John Manns
A Potter Andrew
Original Assignee
University 0F Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University 0F Saskatchewan filed Critical University 0F Saskatchewan
Priority to GR20060100539A priority Critical patent/GR20060100539A/el
Publication of GR20060100539A publication Critical patent/GR20060100539A/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/09Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Περιγράφονται νέα συστήματα ανοσολογικών φορέων, το DNA που τα κωδικοποιεί, καθώς και η χρήση των εν λόγω συστημάτων. Τα συστήματα φορέων περιλαμβάνουν χιμαιρικές πρωτεΐνες οι οποίες περιλαμβάνουν ένα πολυπεπτίδιο λευκοτοξίνης που είναι συντηγμένο σε ένα ή περισσότερα επιλεγμένα πολυμερή GnRH multimers τα οποία περιλαμβάνουν τουλάχιστον μία επαναληπτική αλληλουχία δεκαπεπτιδίων GnRH ή τουλάχιστονμια επαναληπτική μονάδα αλληλουχίας που αντιστοιχεί σε τουλάχιστον έναν επίτοπο ενός επιλεγμένου μορίου GnRH. Σύμφωνα με την εφεύρεση, οι επιλεγμένεςαλληλουχίες GnRH μπορούν να είναι όλες πανομοιότυπες ή να αντιστουχούν σε διαφορετικά παράγωγα, ανάλογα, παραλλαγές ή επιτόπους της GnRH εφόσον οι αλληλουχίες GnRH είναι ικανές να προκαλέσουν ανοσοαντίδραση. Η λευκοτοξίνη συμβάλει στην αύξηση της ανοσογονικότητας των συντηγμένων πολυμερών GnRH.
GR20060100539A 2006-09-29 2006-09-29 ΧΙΜΑΙΡΕΣ GnRH -ΛΕΥΚΟΤΟΞΙΝΩΝ GR20060100539A (el)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20060100539A GR20060100539A (el) 2006-09-29 2006-09-29 ΧΙΜΑΙΡΕΣ GnRH -ΛΕΥΚΟΤΟΞΙΝΩΝ

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20060100539A GR20060100539A (el) 2006-09-29 2006-09-29 ΧΙΜΑΙΡΕΣ GnRH -ΛΕΥΚΟΤΟΞΙΝΩΝ

Publications (1)

Publication Number Publication Date
GR20060100539A true GR20060100539A (el) 2008-04-15

Family

ID=39345393

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20060100539A GR20060100539A (el) 2006-09-29 2006-09-29 ΧΙΜΑΙΡΕΣ GnRH -ΛΕΥΚΟΤΟΞΙΝΩΝ

Country Status (1)

Country Link
GR (1) GR20060100539A (el)

Similar Documents

Publication Publication Date Title
ATE300616T1 (de) Gnrh-leukotoxin-chimäre
MX9706009A (es) Quimeras de gnrh-leucotoxina.
MX2022001134A (es) Proteinas quimericas de factor viii y usos de estas.
WO2007106476A3 (en) Compositions and methods for enhancing the immunogenicity of antigens
WO2004099231A3 (en) Glycopegylation methods and proteins/peptides produced by the methods
NZ606427A (en) Extended recombinant polypeptides and compositions comprising same
ATE353918T1 (de) Zyklische peptide als agonisten für den melanocortin-4-rezeptor
EP3412304A3 (en) Hla-a24 agonist epitopes of muc1-c oncoprotein and compositions and methods of use
WO2015023891A3 (en) Factor viii-xten fusions and uses thereof
WO2009022236A3 (en) Immunogen platform
HK1144305A1 (zh) 衍生自 的癌抗原肽
JP2009529509A5 (el)
WO2007146401A3 (en) Denatured collagen peptides and uses thereof
EA036805B8 (ru) Белок cd24 для подавления ответа хозяина на damp
WO2004087874A3 (en) Novel nucleic acids and polypeptides
MX2008010389A (es) Polipeptidos de union quimerica de plantas para reconocimiento molecular universal.
HK1117595A1 (en) Method for detecting autoimmune antibodies against tsh receptors and novel tsh-receptor chimaeras
ATE387629T1 (de) Gemeinsame epitope von antigenen aus einer multigen-familie
GR20060100539A (el) ΧΙΜΑΙΡΕΣ GnRH -ΛΕΥΚΟΤΟΞΙΝΩΝ
WO2013011184A3 (es) Molécula quimerica util en inmunoterapia frente a la leishmaniosis, que comprende un fragmento de la proteina pfr1 de leishmania infantum con epitopes especificos inmunodominantes
WO2009002939A3 (en) Autophilic antibodies
EP2129359A4 (en) GPCR1 35 OR GPCR1 ANTAGONIST CHIMERIC PEPTIDE 42
NZ605799A (en) Wdrpuh epitope peptides and vaccines containing the same
UA100692C2 (ru) Днк-плазмиды, имеющие повышенную экспрессию и стабильность
WO2009130612A3 (en) Prion epitopes and methods of use thereof

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees

Effective date: 20110404